Project Description

Faraday
A Fireside Chat with Dr. Mark Roth and Dr. Cheerag Shirodaria on Improving Outcomes and Extending Lives

Date & Time:

April 26, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval

About the Event:

Years ago, Dr. Mark Roth started to wonder how people who fall through the ice on frozen lakes can be reanimated after they’ve shown no vital signs for extended periods of time and what impact that might have on health care. What he found was that even though the heart and lungs stopped functioning, the muscles maintained energy. Survivors were simply able to slow their metabolism until help arrived.

Roth founded Faraday Pharmaceuticals and began working on helping patients recover from acute events faster and more completely using the concept of suspended animation. Now in a phase 3 clinical trial, their lead drug FDY-5301 is being used to help people recover completely from heart attacks.

Join our fireside chat on April 26 to hear from Dr. Roth and Dr. Cheerag Shirodaria, a lead researcher on the FDY-5301, as they discuss how it has major implications for everything from surgical recovery to living a longer, healthier life.

Share this Event

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.